glp-1 receptor agonists adverse effects Frontiers GLP-1: Genetic Variants Related to
Description
GLP-1 is both anxiogenic and antidepressant
These are not optional add-ons
Furthermore, recent finding reported that GLP-1 RAs significantly reduced C-reactive protein (CRP) levels in obese IBD patients, alongside a nearly statistically significant reduction in fecal calprotectin (100)
The REDEFINE 1 phase 3 trial showed CagriSema achieved 20.4% mean weight loss at 68 weeks in adults with obesity, with 60% of participants losing at least 20% of body weight ( [140] )
When blood sugar is high, GIP has minimal effect on glucagon
Do not send protected health information through a web form
